Intrathecal Versus Intravenous Dexmedetomidine in Prostate Transurethral Resection
Status:
Not yet recruiting
Trial end date:
2023-04-29
Target enrollment:
Participant gender:
Summary
This study was conducted to compare the effects of intrathecal versus intravenous
dexmedetomidine administration in patients undergoing Transurethral resection of the prostate
under spinal anesthesia.